Johnson Matthey PLC (LON:JMAT – Get Free Report) insider Richard Pike purchased 17,635 shares of Johnson Matthey stock in a transaction dated Friday, September 11th. The stock was bought at an average price of GBX 2,248 per share, with a total value of £396,434.80.
Richard Pike also recently made the following trade(s):
- On Friday, July 10th, Richard Pike purchased 12 shares of Johnson Matthey stock. The stock was purchased at an average price of GBX 1,909 per share, with a total value of £229.08.
Johnson Matthey Price Performance
LON JMAT traded down GBX 2.13 during trading hours on Friday, reaching GBX 2,245.87. The company’s stock had a trading volume of 9,612,290 shares, compared to its average volume of 2,058,961. Johnson Matthey PLC has a 1 year low of GBX 2,218 and a 1 year high of GBX 3,245.33. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. The company has a market capitalization of £2.83 billion, a price-to-earnings ratio of -29.45, a PEG ratio of 49,242.50 and a beta of 0.94. The firm’s 50-day moving average price is GBX 2,106.64 and its 200-day moving average price is GBX 2,053.58.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on JMAT
Johnson Matthey Company Profile
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Featured Stories
- Five stocks we like better than Johnson Matthey
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
